Wire · regulatory
Lupin Announces U.S. FDA Approval and Launch of Sugammadex Injection
◆ Sectors
Health
◆ Geography
United States
◆ Source
◆ Verified
Fusion42 · 31 July 2026 · Fusion42 review
Lupin has received U.S. FDA approval and launched Sugammadex Injection, expanding its pharmaceutical portfolio in the United States with a new specialty drug.
This Wire brief sits within Fusion42's coverage of Health.
◆ ◆ The Wire takeaway
You now have a new FDA-approved drug in the U.S. market that opens a specialty pharmaceutical opportunity. Prepare to engage healthcare providers and payers quickly to capture adoption ahead of competitors.
◆ Coverage
1 source · 31 Jul 2026
◆ Related on Wire
◆ Topics
Healthfda-approvalspecialty-drugus-launchpharma